{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T09:30:27Z","timestamp":1774949427564,"version":"3.50.1"},"reference-count":165,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007210","name":"Varian Medical Systems","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007210","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.brachy.2022.04.004","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:28:47Z","timestamp":1653006527000},"page":"569-591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The American Brachytherapy Society consensus statement for permanent implant brachytherapy using Yttrium-90 microsphere radioembolization for liver tumors"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5163-794X","authenticated-orcid":false,"given":"Navesh K.","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4643-7745","authenticated-orcid":false,"given":"S. Cheenu","family":"Kappadath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8328-7518","authenticated-orcid":false,"given":"Michael","family":"Chuong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2886-0956","authenticated-orcid":false,"given":"Michael","family":"Folkert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1423-4484","authenticated-orcid":false,"given":"Peter","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salma K.","family":"Jabbour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Rohan","family":"Jeyarajah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5891-3609","authenticated-orcid":false,"given":"David","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7585-5738","authenticated-orcid":false,"given":"Joshua E.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Mikell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firas","family":"Mourtada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2022.04.004_bib0001","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.soc.2014.09.011","article-title":"Y90 selective internal radiation therapy","volume":"24","author":"Lee","year":"2015","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.brachy.2022.04.004_bib0002","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/01.RVI.0000164324.79242.B2","article-title":"Angiographic considerations in patients undergoing liver-directed therapy","volume":"16","author":"Liu","year":"2005","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"10.1016\/j.brachy.2022.04.004_bib0003","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00270-007-9064-z","article-title":"Radioembolization with 90Y microspheres: angiographic and technical considerations","volume":"30","author":"Lewandowski","year":"2007","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0004","series-title":"ESTAR, PSTAR, and ASTAR: computer programs for calculating stopping-power and range tables for electrons, protons, and helium ions","author":"Berger","year":"2005"},{"key":"10.1016\/j.brachy.2022.04.004_bib0005","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1002\/jbm.820271010","article-title":"Chemical durability of Y2O3-Al2O3-SiO2 glasses for the in vivo delivery of beta radiation","volume":"27","author":"Erbe","year":"1993","journal-title":"J Biomed Mater Res"},{"key":"10.1016\/j.brachy.2022.04.004_bib0006","unstructured":"Biocompatibles; Therasphere (TM). Package Insert. Biocompatibles UK Ltd, Chapman House Farnham Business Park Weydon Lane FARNHAM, GU9 8QL United Kingdom, 2014."},{"key":"10.1016\/j.brachy.2022.04.004_bib0007","unstructured":"Day D.E., Ehrhardt G.J. Microspheres for radiation therapy. 1994."},{"key":"10.1016\/j.brachy.2022.04.004_bib0008","article-title":"SIR-Sphere (TM). package insert","year":"2011","journal-title":"Sirtex Medical Inc"},{"key":"10.1016\/j.brachy.2022.04.004_bib0009","unstructured":"Gray B.N. Method of treating cancer. 2014."},{"key":"10.1016\/j.brachy.2022.04.004_bib0010","article-title":"SIR-Sphere (TM). package insert","year":"2011","journal-title":"Sirtex Medical Inc"},{"key":"10.1016\/j.brachy.2022.04.004_bib0011","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13550-015-0133-z","article-title":"Evaluation of the delivered activity of yttrium-90 resin microspheres using sterile water and 5% glucose during administration","volume":"5","author":"Ahmadzadehfar","year":"2015","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.brachy.2022.04.004_bib0012","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3892\/br.2016.799","article-title":"Five percent dextrose maximizes dose delivery of Yttrium-90 resin microspheres and reduces rates of premature stasis compared to sterile water","volume":"5","author":"Koran","year":"2016","journal-title":"Biomed Rep"},{"key":"10.1016\/j.brachy.2022.04.004_bib0013","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.2967\/jnumed.115.170779","article-title":"Reduced periprocedural analgesia after replacement of water for injection with glucose 5% solution as the infusion medium for 90Y-resin microspheres","volume":"57","author":"Paprottka","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.brachy.2022.04.004_bib0014","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1245\/s10434-013-3297-7","article-title":"Cause of death from liver metastases in colorectal cancer","volume":"21","author":"Helling","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0015","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/01.sla.0000128305.90650.71","article-title":"Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection\/ablation for colorectal liver metastases","volume":"239","author":"Abdalla","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.brachy.2022.04.004_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djx015","article-title":"Local Treatment of unresectable colorectal liver metastases: results of a randomized phase II trial","volume":"109","author":"Ruers","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.brachy.2022.04.004_bib0017","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1186\/s12885-015-1822-8","article-title":"Phase II trial of selective internal radiation therapy and systemic chemotherapy for liver-predominant metastases from pancreatic adenocarcinoma","volume":"15","author":"Gibbs","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.brachy.2022.04.004_bib0018","doi-asserted-by":"crossref","first-page":"703","DOI":"10.6004\/jnccn.2012.0073","article-title":"Pancreatic adenocarcinoma, version 2.2012: featured updates to the NCCN guidelines","volume":"10","author":"Tempero","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.brachy.2022.04.004_bib0019","first-page":"1395","article-title":"[S3-guideline exocrine pancreatic cancer]","volume":"51","author":"Seufferlein","year":"2013","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11864-016-0402-8","article-title":"Radioembolization as a treatment strategy for metastatic colorectal cancer to the liver: what can we learn from the SIRFLOX trial?","volume":"17","author":"Sangha","year":"2016","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0021","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1200\/JCO.2015.66.1181","article-title":"SIRFLOX: randomized phase III trial comparing first-line mFOLFOX6 (Plus or Minus Bevacizumab) versus mFOLFOX6 (Plus or Minus Bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer","volume":"34","author":"van Hazel","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0022","doi-asserted-by":"crossref","first-page":"614","DOI":"10.21037\/jgo.2017.03.10","article-title":"Updated survival outcomes and analysis of long-term survivors from the MORE study on safety and efficacy of radioembolization in patients with unresectable colorectal cancer liver metastases","volume":"8","author":"Kennedy","year":"2017","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0023","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/hep.29691","article-title":"Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience","volume":"68","author":"Salem","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.brachy.2022.04.004_bib0024","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/JHC.S248314","article-title":"Survival outcomes for Yttrium-90 transarterial radioembolization with and without sorafenib for unresectable hepatocellular carcinoma patients","volume":"7","author":"Teyateeti","year":"2020","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.brachy.2022.04.004_bib0025","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S1470-2045(17)30457-6","article-title":"First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials","volume":"18","author":"Wasan","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0026","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3748\/wjg.v23.i8.1469","article-title":"Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients","volume":"23","author":"Cucchetti","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0027","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/j.tvir.2019.02.003","article-title":"Radiation segmentectomy and radiation lobectomy: a practical review of techniques","volume":"22","author":"Malhotra","year":"2019","journal-title":"Tech Vasc Interv Radiol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jvir.2016.09.024","article-title":"Radioembolization of hepatic malignancies: background, quality improvement guidelines, and future directions","volume":"28","author":"Padia","year":"2017","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0029","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.2214\/AJR.15.15615","article-title":"Transradial approach for hepatic radioembolization: initial results and technique","volume":"207","author":"Bishay","year":"2016","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0030","first-page":"E183","article-title":"Optimized computed tomographic angiography vessel evaluation protocol (OCTAVE) prior to trans\u00adarterial radioembolization","volume":"360","author":"Ng","year":"2016","journal-title":"Intervent Oncol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0031","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.jvir.2013.07.011","article-title":"Prophylactic embolization of the gastroduodenal and right gastric arteries is not routinely necessary before radioembolization with glass microspheres","volume":"24","author":"Hamoui","year":"2013","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0032","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1016\/j.crad.2013.12.015","article-title":"Selective internal radiation therapy of hepatic tumours: is coiling of the gastroduodenal artery always beneficial?","volume":"69","author":"Schelhorn","year":"2014","journal-title":"Clin Radiol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0033","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s00270-016-1310-9","article-title":"Radioembolization: is prophylactic embolization of hepaticoenteric arteries necessary? A systematic review","volume":"39","author":"Borggreve","year":"2016","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0034","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/j.jvir.2013.12.298","article-title":"COSY trial: a prospective, randomized study of coilng vs surefire infusion system in Y90","volume":"25","author":"Fischman","year":"2014","journal-title":"J Vasc and Interventional Radiol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0035","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/s-0031-1280672","article-title":"Radioembolization complicated by nontarget embolization to the falciform artery","volume":"28","author":"Bhalani","year":"2011","journal-title":"Semin Intervent Radiol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0036","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jvir.2012.12.020","article-title":"Prophylactic topically applied ice to prevent cutaneous complications of nontarget chemoembolization and radioembolization","volume":"24","author":"Wang","year":"2013","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0037","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jvir.2009.01.021","article-title":"Incorporating cone-beam CT into the treatment planning for yttrium-90 radioembolization","volume":"20","author":"Louie","year":"2009","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0038","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.2967\/jnumed.109.074559","article-title":"The significance of 99mTc-MAA SPECT\/CT liver perfusion imaging in treatment planning for 90Y-microsphere selective internal radiation treatment","volume":"51","author":"Ahmadzadehfar","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.brachy.2022.04.004_bib0039","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/RLU.0b013e3182393370","article-title":"Identification of the falciform artery on nuclear medicine imaging with successful coil embolization for planned Y-90 therapy","volume":"37","author":"Haggerty","year":"2012","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.brachy.2022.04.004_bib0040","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jvir.2016.12.1221","article-title":"Correlation of Technetium-99m macroaggregated albumin and Yttrium-90 glass microsphere biodistribution in hepatocellular carcinoma: a retrospective review of pretreatment single photon emission CT and posttreatment positron emission tomography\/CT","volume":"28","author":"Haste","year":"2017","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0041","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ijrobp.2012.06.051","article-title":"Lung dose calculation with SPECT\/CT for 90Yittrium radioembolization of liver cancer","volume":"85","author":"Yu","year":"2013","journal-title":"Int J Radiation Oncol*Biol*Physics"},{"key":"10.1016\/j.brachy.2022.04.004_bib0042","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1007\/s00259-014-2784-9","article-title":"99mTc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with 166Ho-microspheres","volume":"41","author":"Elschot","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.brachy.2022.04.004_bib0043","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13550-014-0033-7","article-title":"Personalized predictive lung dosimetry by technetium-99m macroaggregated albumin SPECT\/CT for yttrium-90 radioembolization","volume":"4","author":"Kao","year":"2014","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.brachy.2022.04.004_bib0044","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13550-018-0402-8","article-title":"The value of 99mTc-MAA SPECT\/CT for lung shunt estimation in 90Y radioembolization: a phantom and patient study","volume":"8","author":"Allred","year":"2018","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.brachy.2022.04.004_bib0045","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.2967\/jnumed.117.205203","article-title":"A prospective study of quantitative SPECT\/CT for evaluation of lung shunt fraction before SIRT of liver tumors","volume":"59","author":"Dittmann","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.brachy.2022.04.004_bib0046","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1002\/mp.13575","article-title":"Calculation of lung mean dose and quantification of error for (90) Y-microsphere radioembolization using (99m) Tc-MAA SPECT\/CT and diagnostic chest CT","volume":"46","author":"Lopez","year":"2019","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2022.04.004_bib0047","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1007\/s00259-018-4064-6","article-title":"Radioembolization with 90Y glass microspheres for hepatocellular carcinoma: significance of pretreatment 11C-acetate and 18F-FDG PET\/CT and posttreatment 90Y PET\/CT in individualized dose prescription","volume":"45","author":"Ho","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.brachy.2022.04.004_bib0048","doi-asserted-by":"crossref","DOI":"10.1118\/1.4830433","article-title":"Evaluation of a semiautomated lung mass calculation technique for internal dosimetry applications","volume":"40","author":"Busse","year":"2013","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2022.04.004_bib0049","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1002\/mp.12483","article-title":"Impact of respiratory motion and acquisition settings on SPECT liver dosimetry for radioembolization","volume":"44","author":"Bastiaannet","year":"2017","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2022.04.004_bib0050","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40658-015-0119-y","article-title":"Comparing voxel-based absorbed dosimetry methods in tumors, liver, lung, and at the liver-lung interface for (90)Y microsphere selective internal radiation therapy","volume":"2","author":"Mikell","year":"2015","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.brachy.2022.04.004_bib0051","doi-asserted-by":"crossref","first-page":"32","DOI":"10.23736\/S1824-4785.20.03287-2","article-title":"Lung shunt and lung dose calculation methods for radioembolization treatment planning","volume":"65","author":"Kappadath","year":"2021","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1016\/j.brachy.2022.04.004_bib0052","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1097\/MNM.0000000000001439","article-title":"Reassessment of the lung dose limits for radioembolization","volume":"42","author":"Kappadath","year":"2021","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.brachy.2022.04.004_bib0053","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1007\/s00259-015-3048-z","article-title":"Fusion dual-tracer SPECT-based hepatic dosimetry predicts outcome after radioembolization for a wide range of tumour cell types","volume":"42","author":"Lam","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.brachy.2022.04.004_bib0054","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s00259-020-04686-1","article-title":"Quantifying the effects of absorbed dose from radioembolisation on healthy liver function with [(99m)Tc]TcMebrofenin","volume":"47","author":"Willowson","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.brachy.2022.04.004_bib0055","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2967\/jnumed.109.069278","article-title":"Hepatic structural dosimetry in (90)Y microsphere treatment: a Monte Carlo modeling approach based on lobular microanatomy","volume":"51","author":"Gulec","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.brachy.2022.04.004_bib0056","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jvir.2014.03.025","article-title":"The limitations of theoretical dose modeling for yttrium-90 radioembolization","volume":"25","author":"Liu","year":"2014","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0057","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/abf38a","article-title":"Post-administration dosimetry in yttrium-90 radioembolization through micro-CT imaging of radiopaque microspheres in a porcine renal model","volume":"66","author":"Henry","year":"2021","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0058","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.adro.2016.08.003","article-title":"The development, commercialization, and clinical context of yttrium-90 radiolabeled resin and glass microspheres","volume":"1","author":"Westcott","year":"2016","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0059","first-page":"15","article-title":"Down and dirty with Dosimetry A practical understanding and approach to radioembolization","author":"Liu","year":"2016","journal-title":"Endovascular Today"},{"key":"10.1016\/j.brachy.2022.04.004_bib0060","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.jvir.2013.11.018","article-title":"Limitations of body surface area\u2013based activity calculation for radioembolization of hepatic metastases in colorectal cancer","volume":"25","author":"Lam","year":"2014","journal-title":"J Vasc and Interventional Radiol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0061","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/BF01084369","article-title":"Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours","volume":"23","author":"Ho","year":"1996","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.brachy.2022.04.004_bib0062","first-page":"11S","article-title":"MIRD Pamphlet No. 17: the dosimetry of nonuniform activity distributions\u2013radionuclide s values at the voxel level","volume":"40","author":"Bolch","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1016\/j.brachy.2022.04.004_bib0063","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.2967\/jnumed.110.077149","article-title":"Fine-resolution voxel s values for constructing absorbed dose distributions at variable voxel size","volume":"51","author":"Dieudonne","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.brachy.2022.04.004_bib0064","doi-asserted-by":"crossref","unstructured":"Amato E., Minutoli F., Pacilio M., et al. An analytical method for computing voxel S values for electrons and photons. Med Physics. 2012 2012\/11\/01;39:6808\u201317.","DOI":"10.1118\/1.4757912"},{"key":"10.1016\/j.brachy.2022.04.004_bib0065","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1088\/0031-9155\/57\/2\/517","article-title":"A free database of radionuclide voxel S values for the dosimetry of nonuniform activity distributions","volume":"57","author":"Lanconelli","year":"2012","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0066","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1088\/0031-9155\/59\/17\/4769","article-title":"A new approach for dose calculation in targeted radionuclide therapy (TRT) based on collapsed cone superposition: validation with 90Y","volume":"59","author":"Sanchez-Garcia","year":"2014","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0067","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1088\/0031-9155\/61\/12\/4564","article-title":"Evaluation of a deterministic grid-based Boltzmann solver (GBBS) for voxel-level absorbed dose calculations in nuclear medicine","volume":"61","author":"Mikell","year":"2016","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0068","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.2967\/jnumed.106.038000","article-title":"Three-dimensional radiobiologic dosimetry: application of radiobiologic modeling to patient-specific 3-dimensional imaging-based internal Dosimetry","volume":"48","author":"Prideaux","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.brachy.2022.04.004_bib0069","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1109\/TMI.2009.2022753","article-title":"Effect of voxel size and computation method on Tc-99m MAA SPECT\/CT-based dose estimation for Y-90 microsphere therapy","volume":"28","author":"Pasciak","year":"2009","journal-title":"IEEE Trans Med Imaging"},{"key":"10.1016\/j.brachy.2022.04.004_bib0070","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2967\/jnumed.112.105825","article-title":"Study of the impact of tissue density heterogeneities on 3-dimensional abdominal dosimetry: comparison between dose kernel convolution and direct Monte Carlo methods","volume":"54","author":"Dieudonn\u00e9","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.brachy.2022.04.004_bib0071","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ijrobp.2016.07.021","article-title":"Selective internal radiation therapy with yttrium-90 glass microspheres: biases and uncertainties in absorbed dose calculations between clinical dosimetry models","volume":"96","author":"Mikell","year":"2016","journal-title":"Int J Radiation Oncol*Biol*Physics"},{"key":"10.1016\/j.brachy.2022.04.004_bib0072","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.jvir.2018.07.006","article-title":"Tumor targeting and three-dimensional voxel-based dosimetry to predict tumor response, toxicity, and survival after Yttrium-90 resin microsphere radioembolization in hepatocellular carcinoma","volume":"29","author":"Allimant","year":"2018","journal-title":"J Vasc and Interventional Radiol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0073","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1088\/1361-6560\/aa5088","article-title":"Effects of image noise, respiratory motion, and motion compensation on 3D activity quantification in count-limited PET images","volume":"62","author":"Siman","year":"2017","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0074","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1002\/mp.14117","article-title":"Systematic and random errors of PET-based (90) Y 3D dose quantification","volume":"47","author":"Siman","year":"2020","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2022.04.004_bib0075","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ijrobp.2018.05.062","article-title":"Hepatocellular carcinoma tumor dose response after (90)Y-radioembolization with glass microspheres using (90)Y-SPECT\/CT-based voxel dosimetry","volume":"102","author":"Kappadath","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.04.004_bib0076","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/mp.12695","article-title":"Characterization of 90Y-SPECT\/CT self-calibration approaches on the quantification of voxel-level absorbed doses following 90Y-microsphere selective internal radiation therapy","volume":"45","author":"Balagopal","year":"2017","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2022.04.004_bib0077","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1007\/s00259-010-1470-9","article-title":"Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres","volume":"37","author":"Lhommel","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.brachy.2022.04.004_bib0078","doi-asserted-by":"crossref","DOI":"10.1118\/1.4810939","article-title":"3D inpatient dose reconstruction from the PET-CT imaging of 90Y microspheres for metastatic cancer to the liver: feasibility study","volume":"40","author":"Fourkal","year":"2013","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2022.04.004_bib0079","doi-asserted-by":"crossref","unstructured":"Carlier T., Willowson K.P., Fourkal E., et al. 90Y -PET imaging: exploring limitations and accuracy under conditions of low counts and high random fraction. Medical Physics. 2015 2015\/07\/01;42:4295\u2013309.","DOI":"10.1118\/1.4922685"},{"key":"10.1016\/j.brachy.2022.04.004_bib0080","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1007\/s00259-015-3059-9","article-title":"A multicentre comparison of quantitative 90Y PET\/CT for dosimetric purposes after radioembolization with resin microspheres","volume":"42","author":"Willowson","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.brachy.2022.04.004_bib0081","first-page":"633","article-title":"90Y PET-based dosimetry after selective internal radiotherapy treatments","volume":"33","author":"D'Arienzo","year":"2012","journal-title":"Nuclear Medicine Communications June 2012"},{"key":"10.1016\/j.brachy.2022.04.004_bib0082","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2967\/jnmt.117.195438","article-title":"Comparison of step-and-shoot and continuous-bed-motion PET modes of acquisition for limited-view organ scans","volume":"45","author":"Siman","year":"2017","journal-title":"J Nucl Med Technol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0083","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/mp.13269","article-title":"Dose volume histogram-based optimization of image reconstruction parameters for quantitative (90) Y-PET imaging","volume":"46","author":"Siman","year":"2019","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2022.04.004_sbref10086","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1118\/1.4960629","article-title":"Practical reconstruction protocol for quantitative 90Y bremsstrahlung SPECT\/CT","author":"Siman","year":"2016","journal-title":"Med. Phys."},{"key":"10.1016\/j.brachy.2022.04.004_bib0085","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1118\/1.3700174","article-title":"Development and evaluation of an improved quantitative [sup 90]Y bremsstrahlung SPECT method","volume":"39","author":"Rong","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2022.04.004_sbref0086","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.2967\/jnumed.112.119131","article-title":"Quantitative Monte Carlo\u2013based 90Y SPECT reconstruction","author":"Elschot","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.brachy.2022.04.004_bib0087","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1002\/mp.12597","article-title":"Improved quantitative 90Y bremsstrahlung SPECT\/CT reconstruction with Monte Carlo scatter modeling","volume":"12","author":"Dewaraja","year":"2017","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2022.04.004_bib0088","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/aac1ad","article-title":"Y-90 SPECT ML image reconstruction with a new model for tissue-dependent bremsstrahlung production using CT information: a proof-of-concept study","volume":"63","author":"Lim","year":"2018","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0089","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1120\/jacmp.v14i5.4371","article-title":"Patient dosimetry for 90Y selective internal radiation treatment based on 90Y PET imaging","volume":"14","author":"Ng","year":"2013","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.brachy.2022.04.004_bib0090","doi-asserted-by":"crossref","DOI":"10.1118\/1.4892383","article-title":"PET optimization for improved assessment and accurate quantification of 90Y-microsphere biodistribution after radioembolization","volume":"41","author":"Mart\u00ed-Climent","year":"2014","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2022.04.004_bib0091","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/RLU.0000000000001385","article-title":"90Y Digital PET\/CT imaging following radioembolization","volume":"41","author":"Wright","year":"2016","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1016\/j.brachy.2022.04.004_bib0092","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40658-018-0222-y","article-title":"Comparison of PET\/CT and PET\/MR imaging and dosimetry of yttrium-90 (90Y) in patients with unresectable hepatic tumors who have received intra-arterial radioembolization therapy with 90Y microspheres","volume":"5","author":"Kne\u0161aurek","year":"2018","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.brachy.2022.04.004_bib0093","first-page":"7","article-title":"ICRP Publication 107. Nuclear decay data for dosimetric calculations","volume":"38","author":"Eckerman","year":"2008","journal-title":"Ann ICRP"},{"key":"10.1016\/j.brachy.2022.04.004_bib0094","first-page":"1024","article-title":"Bremsstrahlung radiation exposure from pure \u03b2-Ray emitters","volume":"40","author":"Zanzonico","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1016\/j.brachy.2022.04.004_bib0095","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.2967\/jnumed.107.045443","article-title":"Posttherapy radiation safety considerations in radiomicrosphere treatment with 90Y-microspheres","volume":"48","author":"Gulec","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.brachy.2022.04.004_bib0096","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1118\/1.3608909","article-title":"Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for [sup 90]Y microsphere brachytherapy in the treatment of hepatic malignancies","volume":"38","author":"Dezarn","year":"2011","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2022.04.004_bib0097","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s00259-011-1812-2","article-title":"EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds","volume":"38","author":"Giammarile","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.brachy.2022.04.004_bib0098","unstructured":"Erwin W.D. Radiation safety concerns associated with preparing the dosage, treating and releasing the patient, and managing radioactive waste. Handbook of Radioembolization 2016."},{"key":"10.1016\/j.brachy.2022.04.004_bib0099","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.1002\/mp.14452","article-title":"Planning dosimetry for (90) Y radioembolization with glass microspheres: evaluating the fidelity of (99m) Tc-MAA and partition model predictions","volume":"47","author":"Thomas","year":"2020","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2022.04.004_bib0100","doi-asserted-by":"crossref","first-page":"S545","DOI":"10.1016\/j.hpb.2021.06.180","article-title":"A prospective, multicenter, open-label, clinical trial design to evaluate the safety and efficacy of 90Y resin microspheres for treatment of unresectable hepatocellular carcinoma (HCC): dOORwaY90","volume":"23","author":"Mahvash","year":"2021","journal-title":"HPB"},{"key":"10.1016\/j.brachy.2022.04.004_bib0101","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00259-019-04340-5","article-title":"Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group","volume":"46","author":"Salem","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.brachy.2022.04.004_bib0102","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1007\/s00259-020-05163-5","article-title":"International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres","volume":"48","author":"Levillain","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.brachy.2022.04.004_bib0103","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijrobp.2013.05.041","article-title":"Safety of 90Y radioembolization in patients who have undergone previous external beam radiation therapy","volume":"87","author":"Lam","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.04.004_bib0104","article-title":"Combined Yttrium-90 microsphere selective internal radiation therapy and external beam radiotherapy in patients with hepatocellular carcinoma: from clinical aspects to dosimetry","volume":"13","author":"Wang","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.brachy.2022.04.004_bib0105","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2214\/ajr.147.2.275","article-title":"Interstitial radiation therapy for hepatic metastases: sonographic guidance for applicator placement","volume":"147","author":"Dritschilo","year":"1986","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0106","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.ijrobp.2003.09.024","article-title":"CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique","volume":"58","author":"Ricke","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.04.004_bib0107","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/01.RVI.0000141343.43441.06","article-title":"Liver malignancies: cT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation","volume":"15","author":"Ricke","year":"2004","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0108","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijrobp.2009.07.1700","article-title":"Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival","volume":"78","author":"Mohnike","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.04.004_bib0109","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijrobp.2009.09.026","article-title":"Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy","volume":"78","author":"Ricke","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.04.004_bib0110","doi-asserted-by":"crossref","first-page":"e509","DOI":"10.1016\/j.ejrad.2013.04.046","article-title":"Computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of metastases adjacent to the liver hilum","volume":"82","author":"Collettini","year":"2013","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0111","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1007\/s00330-013-2816-z","article-title":"Computed tomography-guided interstitial high dose rate brachytherapy for centrally located liver tumours: a single institution study","volume":"23","author":"Tselis","year":"2013","journal-title":"Eur Radiol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0112","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.brachy.2012.02.006","article-title":"Hypofractionated accelerated computed tomography-guided interstitial high-dose-rate brachytherapy for liver malignancies","volume":"11","author":"Tselis","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2022.04.004_bib0113","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00066-018-1404-1","article-title":"Biliary duct stenosis after image-guided high-dose-rate interstitial brachytherapy of central and hilar liver tumors: a systematic analysis of 102 cases","volume":"195","author":"Powerski","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0114","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1055\/a-0636-4055","article-title":"Ultrasound-assisted catheter placement in CT-guided HDR brachytherapy for the local ablation of abdominal malignancies: initial experience","volume":"191","author":"Damm","year":"2019","journal-title":"Rofo"},{"key":"10.1016\/j.brachy.2022.04.004_bib0115","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jvir.2019.05.012","article-title":"Feasibility and safety of CT-guided high-dose-rate brachytherapy combined with transarterial chemoembolization using irinotecan-loaded microspheres for the treatment of large, unresectable colorectal liver metastases","volume":"31","author":"Collettini","year":"2020","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0116","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1148\/radiographics.21.suppl_1.g01oc11s17","article-title":"Essential techniques for successful radio-frequency thermal ablation of malignant hepatic tumors","author":"Rhim","year":"2001","journal-title":"Radiographics"},{"key":"10.1016\/j.brachy.2022.04.004_bib0117","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1067\/msy.2002.127545","article-title":"Radiofrequency ablation of liver tumors: influence of technique and tumor size","volume":"132","author":"Kuvshinoff","year":"2002","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.brachy.2022.04.004_bib0118","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.ijrobp.2009.06.092","article-title":"Radiation-associated liver injury","volume":"76","author":"Pan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.04.004_bib0119","first-page":"178","article-title":"Radioembolization of hepatic tumors","volume":"5","author":"Kennedy","year":"2014","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0120","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.14694\/EdBook_AM.2014.34.e150","article-title":"Radiation oncology approaches in liver malignancies","author":"Kennedy","year":"2014","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.brachy.2022.04.004_bib0121","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s00330-011-2352-7","article-title":"Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5-7cm) and very large (>7cm) tumours","volume":"22","author":"Collettini","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0122","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1245\/s10434-017-5950-z","article-title":"The Post-SIR-Spheres Surgery Study (P4S): retrospective analysis of safety following hepatic resection or transplantation in patients previously treated with selective internal radiation therapy with yttrium-90 resin microspheres","volume":"24","author":"Pardo","year":"2017","journal-title":"Annals of surgical oncology"},{"key":"10.1016\/j.brachy.2022.04.004_bib0123","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s00595-020-02088-2","article-title":"Issues to be considered to address the future liver remnant prior to major hepatectomy","volume":"51","author":"Kishi","year":"2021","journal-title":"Surgery Today"},{"key":"10.1016\/j.brachy.2022.04.004_bib0124","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/01.RVI.0000159543.28222.73","article-title":"Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care","volume":"16","author":"Madoff","year":"2005","journal-title":"Journal of vascular and interventional radiology"},{"issue":"3","key":"10.1016\/j.brachy.2022.04.004_bib0125","doi-asserted-by":"crossref","DOI":"10.1053\/j.semnuclmed.2019.01.009","article-title":"Neoadjuvant radiation lobectomy as an alternative to portal vein embolization in hepatocellular carcinoma","volume":"49","author":"Gabr","year":"2019","journal-title":"Seminars in nuclear medicine"},{"key":"10.1016\/j.brachy.2022.04.004_bib0126","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1245\/s10434-021-10219-3","article-title":"Neoadjuvant chemoradiation impacts the prognostic effect of surgical margin status in pancreatic adenocarcinoma","volume":"29","author":"Zhang","year":"2022","journal-title":"Annals of surgical oncology"},{"key":"10.1016\/j.brachy.2022.04.004_bib0127","first-page":"e617","article-title":"Effect of primary tumor side on survival outcomes in untreated patients with metastatic colorectal cancer when selective internal radiation therapy is added to chemotherapy: combined analysis of two randomized controlled studies","volume":"12","author":"Gibbs","year":"2018","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.brachy.2022.04.004_bib0128","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.clcc.2013.11.010","article-title":"Phase I trial of selective internal radiation therapy for chemorefractory colorectal cancer liver metastases progressing after hepatic arterial pump and systemic chemotherapy","volume":"13","author":"Sofocleous","year":"2014","journal-title":"Clinical Colorectal Cancer"},{"key":"10.1016\/j.brachy.2022.04.004_bib0129","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1245\/s10434-017-6265-9","article-title":"Effectiveness of hepatic artery infusion (HAI) versus selective internal radiation therapy (Y90) for pretreated isolated unresectable colorectal liver metastases (IU-CRCLM)","volume":"25","author":"Dhir","year":"2018","journal-title":"Annals of Surgical Oncology"},{"key":"10.1016\/j.brachy.2022.04.004_bib0130","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/jso.20609","article-title":"Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation","volume":"94","author":"Kulik","year":"2006","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0131","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.jhep.2019.08.006","article-title":"Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma","volume":"71","author":"Ricke","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0132","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1245\/s10434-014-4012-z","article-title":"Liver resection for metastatic disease after y90 radioembolization: a case series with long-term follow-up","volume":"22","author":"Henry","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0133","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/bjs.11283","article-title":"Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial","volume":"12","author":"Garlipp","year":"2019","journal-title":"Br J Surg"},{"key":"10.1016\/j.brachy.2022.04.004_bib0134","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.semradonc.2012.11.003","article-title":"Physics controversies in proton therapy","volume":"23","author":"Engelsman","year":"2013","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0135","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0360-3016(02)02846-8","article-title":"Ten Haken RK. Analysis of radiation-induced liver disease using the Lyman NTCP model","volume":"53","author":"Dawson","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.04.004_bib0136","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.semradonc.2005.04.005","article-title":"Partial volume tolerance of the liver to radiation","volume":"15","author":"Dawson","year":"2005","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0137","doi-asserted-by":"crossref","first-page":"e529","DOI":"10.1016\/j.ijrobp.2011.05.056","article-title":"Evaluation of liver function after proton beam therapy for hepatocellular carcinoma","volume":"82","author":"Mizumoto","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.04.004_bib0138","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.ijrobp.2010.07.015","article-title":"Proton beam therapy for hepatocellular carcinoma: a comparison of three treatment protocols","volume":"81","author":"Mizumoto","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.04.004_bib0139","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1748-717X-9-26","article-title":"Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma","volume":"9","author":"Makita","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0140","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.semradonc.2018.06.008","article-title":"Proton beam therapy and carbon ion radiotherapy for hepatocellular carcinoma","volume":"28","author":"Apisarnthanarax","year":"2018","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0141","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.radonc.2018.10.041","article-title":"Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma","volume":"133","author":"Chadha","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0142","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3389\/fonc.2019.00457","article-title":"Consensus report from the Miami liver proton therapy conference","volume":"9","author":"Chuong","year":"2019","journal-title":"Front Oncol."},{"key":"10.1016\/j.brachy.2022.04.004_bib0143","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijrobp.2019.01.076","article-title":"Protons versus photons for unresectable hepatocellular carcinoma: liver decompensation and overall survival","volume":"105","author":"Sanford","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.04.004_bib0144","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1002\/cncr.26134","article-title":"Clinical results and risk factors of proton and carbon ion therapy for hepatocellular carcinoma","volume":"117","author":"Komatsu","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2022.04.004_bib0145","unstructured":"ASTRO. Model policy for proton beam therapy. 2018."},{"key":"10.1016\/j.brachy.2022.04.004_bib0146","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx031","article-title":"Phase II study of proton-based stereotactic body radiation therapy for liver metastases: importance of tumor genotype","volume":"109","author":"Hong","year":"2017","journal-title":"JNCI: Journal of the National Cancer Institute"},{"key":"10.1016\/j.brachy.2022.04.004_bib0147","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1200\/JCO.2005.00.620","article-title":"Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma","volume":"23","author":"Kawashima","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0148","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.2015.64.2710","article-title":"Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"34","author":"Hong","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0149","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ijrobp.2009.02.030","article-title":"Proton beam therapy for large hepatocellular carcinoma","volume":"76","author":"Sugahara","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.04.004_bib0150","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/jrr\/rry056","article-title":"A validated proton beam therapy patch-field protocol for effective treatment of large hepatocellular carcinoma","volume":"59","author":"Nakamura","year":"2018","journal-title":"J Radiat Res"},{"key":"10.1016\/j.brachy.2022.04.004_bib0151","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.surg.2016.11.034","article-title":"Proton beam radiation as salvage therapy for bilateral colorectal liver metastases not amenable to second-stage hepatectomy","volume":"161","author":"Colbert","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.brachy.2022.04.004_bib0152","article-title":"How small is TOO small? New liver constraint is needed- Proton therapy of hepatocellular carcinoma patients with small normal liver","volume":"13","author":"Lee","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.brachy.2022.04.004_bib0153","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijrobp.2019.02.032","article-title":"Predictors of radiation-induced liver disease in eastern and western patients with hepatocellular carcinoma undergoing proton beam therapy","volume":"105","author":"Hsieh","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2022.04.004_bib0154","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1088\/0031-9155\/56\/16\/R01","article-title":"Motion in radiotherapy: particle therapy","volume":"56","author":"Bert","year":"2011","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0155","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/cas.13145","article-title":"Long-term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma","volume":"108","author":"Fukuda","year":"2017","journal-title":"Cancer Sci"},{"key":"10.1016\/j.brachy.2022.04.004_bib0156","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/aaecfc","article-title":"Motion effects in proton treatments of hepatocellular carcinoma-4D robustly optimised pencil beam scanning plans versus double scattering plans","volume":"63","author":"Pfeiler","year":"2018","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0157","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20120288","article-title":"Treatment planning optimisation in proton therapy","volume":"86","author":"McGowan","year":"2013","journal-title":"Br J Radiol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0158","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1200\/JCO.2006.06.7629","article-title":"Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203","volume":"24","author":"G\u00e9rard","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0159","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1023\/A:1013569329846","article-title":"Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer","volume":"12","author":"Gray","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0160","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/jso.20141","article-title":"Randomised phase 2 trial of SIR-Spheres plus fluorouracil\/leucovorin chemotherapy versus fluorouracil\/leucovorin chemotherapy alone in advanced colorectal cancer","volume":"88","author":"Van Hazel","year":"2004","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0161","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1200\/JCO.2010.28.5643","article-title":"Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy","volume":"28","author":"Hendlisz","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0162","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1200\/JCO.2008.20.8116","article-title":"Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy","volume":"27","author":"van Hazel","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0163","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/17474124.2019.1570135","article-title":"Efficacy and safety of selective internal radiotherapy versus sorafenib for intermediate-locally advanced hepatocellular carcinoma: a systematic review and meta-analysis","volume":"13","author":"Zou","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0164","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.21037\/jgo.2017.09.10","article-title":"Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus","volume":"8","author":"Kennedy","year":"2017","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.brachy.2022.04.004_bib0165","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jnci\/djs629","article-title":"Combining radiotherapy and cancer immunotherapy: a paradigm shift","volume":"105","author":"Formenti","year":"2013","journal-title":"J Natl Cancer Inst"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472122000721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472122000721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:17:41Z","timestamp":1761531461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472122000721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":165,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1538472122000721"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2022.04.004","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The American Brachytherapy Society consensus statement for permanent implant brachytherapy using Yttrium-90 microsphere radioembolization for liver tumors","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2022.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}